IMPROVE研究是否会削弱人们对降低低密度脂蛋白或依泽替米贝的信心？ - Suppr

Suppr

超能文献

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

作者信息

Brown B Greg, Taylor Allen J

出版信息

N Engl J Med. 2008 Apr 3;358(14):1504-7. doi: 10.1056/NEJMe0801608. Epub 2008 Mar 30.

DOI:10.1056/NEJMe0801608

PMID:18376002

Abstract

摘要

相似文献

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

N Engl J Med. 2008 Apr 3;358(14):1504-7. doi: 10.1056/NEJMe0801608. Epub 2008 Mar 30.

Cholesterol lowering and ezetimibe.

N Engl J Med. 2008 Apr 3;358(14):1507-8. doi: 10.1056/NEJMe0801842. Epub 2008 Mar 30.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):530; author reply 532-3.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):529; author reply 532. doi: 10.1056/NEJMc080981.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):529-30; author reply 532.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):531; author reply 532-3.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Epub 2008 Mar 30.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):530; author reply 532.

Is there a problem with ezetimibe or just ENHANCEd hype?

Angiology. 2008;59(6):661-3. doi: 10.1177/0003319708321188. Epub 2008 Sep 15.

ENHANCE: food for the ostriches.

Int J Clin Pract. 2008 May;62(5):667-8. doi: 10.1111/j.1742-1241.2008.01740.x.

引用本文的文献

The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic Control.

J Manag Care Spec Pharm. 2018 Sep;24(9):856-861. doi: 10.18553/jmcp.2018.24.9.856.

Beyond Statins: Emerging Evidence for HDL-Increasing Therapies and Diet in Treating Cardiovascular Disease.

Adv Prev Med. 2018 Jul 9;2018:6024747. doi: 10.1155/2018/6024747. eCollection 2018.

Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Drugs. 2015 Jul;75(11):1201-28. doi: 10.1007/s40265-015-0429-3.

Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.

Drugs Aging. 2014 Sep;31(9):683-94. doi: 10.1007/s40266-014-0200-6.

Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.

JAMA Intern Med. 2014 Sep;174(9):1486-93. doi: 10.1001/jamainternmed.2014.3404.

Ezetimibe therapy: mechanism of action and clinical update.

Vasc Health Risk Manag. 2012;8:415-27. doi: 10.2147/VHRM.S33664. Epub 2012 Jul 3.

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

Curr Atheroscler Rep. 2011 Feb;13(1):95-100. doi: 10.1007/s11883-010-0151-2.

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.

Vasc Health Risk Manag. 2010 Nov 10;6:1023-37. doi: 10.2147/VHRM.S13496.

Identification of novel inhibitors of dietary lipid absorption using zebrafish.

PLoS One. 2010 Aug 25;5(8):e12386. doi: 10.1371/journal.pone.0012386.

Drug treatment of hyperlipidaemia: a guide to the rational use of lipid-lowering drugs.

Drugs. 2010 Jul 30;70(11):1363-79. doi: 10.2165/10898610-000000000-00000.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

N Engl J Med. 2008 Apr 3;358(14):1504-7. doi: 10.1056/NEJMe0801608. Epub 2008 Mar 30.

Cholesterol lowering and ezetimibe.

N Engl J Med. 2008 Apr 3;358(14):1507-8. doi: 10.1056/NEJMe0801842. Epub 2008 Mar 30.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):530; author reply 532-3.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):529; author reply 532. doi: 10.1056/NEJMc080981.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):529-30; author reply 532.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):531; author reply 532-3.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Epub 2008 Mar 30.

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

N Engl J Med. 2008 Jul 31;359(5):530; author reply 532.

Is there a problem with ezetimibe or just ENHANCEd hype?

Angiology. 2008;59(6):661-3. doi: 10.1177/0003319708321188. Epub 2008 Sep 15.

ENHANCE: food for the ostriches.

Int J Clin Pract. 2008 May;62(5):667-8. doi: 10.1111/j.1742-1241.2008.01740.x.

引用本文的文献

The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic Control.

J Manag Care Spec Pharm. 2018 Sep;24(9):856-861. doi: 10.18553/jmcp.2018.24.9.856.

Beyond Statins: Emerging Evidence for HDL-Increasing Therapies and Diet in Treating Cardiovascular Disease.

Adv Prev Med. 2018 Jul 9;2018:6024747. doi: 10.1155/2018/6024747. eCollection 2018.

Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.

Drugs. 2015 Jul;75(11):1201-28. doi: 10.1007/s40265-015-0429-3.

Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.

Drugs Aging. 2014 Sep;31(9):683-94. doi: 10.1007/s40266-014-0200-6.

Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010.

JAMA Intern Med. 2014 Sep;174(9):1486-93. doi: 10.1001/jamainternmed.2014.3404.

Ezetimibe therapy: mechanism of action and clinical update.

Vasc Health Risk Manag. 2012;8:415-27. doi: 10.2147/VHRM.S33664. Epub 2012 Jul 3.

Therapies targeting exogenous cholesterol uptake: new insights and controversies.

Curr Atheroscler Rep. 2011 Feb;13(1):95-100. doi: 10.1007/s11883-010-0151-2.

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.

Vasc Health Risk Manag. 2010 Nov 10;6:1023-37. doi: 10.2147/VHRM.S13496.

Identification of novel inhibitors of dietary lipid absorption using zebrafish.

PLoS One. 2010 Aug 25;5(8):e12386. doi: 10.1371/journal.pone.0012386.

Drug treatment of hyperlipidaemia: a guide to the rational use of lipid-lowering drugs.

Drugs. 2010 Jul 30;70(11):1363-79. doi: 10.2165/10898610-000000000-00000.